Literature DB >> 31247236

Dl-3-N-Butylphthalide Alleviates the Blood-Brain Barrier Permeability of Focal Cerebral Ischemia Reperfusion in Mice.

Jiamin Li1, Yang Liu2, Xiangjian Zhang3, Rong Chen4, Lan Zhang4, Jing Xue4, Xuan Gao4.   

Abstract

Ischemic stroke occurs following arterial occlusion and subsequent blood flow cease, and restoration of blood supply by thrombolytic therapy may cause cerebral ischemic reperfusion (IR) injury resulting in breakdowns of blood-brain barrier (BBB). Dl-3-n-butylphthalide (NBP) is an extraction from Chinese celery Apium graveolens Linn seeds and has neuroprotective effects in ischemic stroke. This study explored effects of NBP on BBB disruption caused by cerebral IR and transformation of tight junctions (TJs)-associated proteins and caveolae. Our results demonstrated that NBP alleviated cerebral IR-induced deterioration of vascular permeability by up-regulating TJ-associated proteins but down-regulating caveolin-1. NBP significantly improved neurological function and cerebral blood flow but reduced cerebral edema and infarct volume after IR. In conclusion, NBP exerts neuroprotective effects through attenuating cerebral infarct volume and neurological deficit score, reducing cerebral edema and BBB permeability. The neuroprotective effect of NBP is possibly related to its ability to improve blood flow in cerebral ischemic areas. NBP may turn into a novel treatment drug to prevent BBB dysfunction in ischemic stroke.
Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dl-3-n-butylphthalide(NBP); blood-brain barrier; caveolin-1; ischemia-reperfusion injury; ischemic stroke; tight junction proteins

Mesh:

Substances:

Year:  2019        PMID: 31247236     DOI: 10.1016/j.neuroscience.2019.06.020

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

Review 1.  Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke.

Authors:  Ting Zhu; Lei Wang; Yicheng Feng; Guibo Sun; Xiaobo Sun
Journal:  Oxid Med Cell Longev       Date:  2021-03-13       Impact factor: 6.543

2.  DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials.

Authors:  Huan Wang; Kaili Ye; Dan Li; Yuxin Liu; Deren Wang
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

3.  Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke.

Authors:  Yuanxiang Huang; Xiangjian Zhang; Cong Zhang; Wenting Xu; Wenshuo Li; Zixin Feng; Xianglan Zhang; Keke Zhao
Journal:  Mediators Inflamm       Date:  2022-08-18       Impact factor: 4.529

4.  Dl-3-n-Butylphthalide (NBP) Mitigates Muscular Injury Induced by Limb Ischemia/Reperfusion in Mice through the HMGB1/TLR4/NF-κB Pathway.

Authors:  Huanhuan Sun; Jueqiong Wang; Wei Bi; Feng Zhang; Kui Chi; Long Shi; Meng Li; Jinwen Zhang; Yanrong Zhang; Xiang Gao
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-26       Impact factor: 2.650

Review 5.  Natural Products in the Prevention of Metabolic Diseases: Lessons Learned from the 20th KAST Frontier Scientists Workshop.

Authors:  Seung J Baek; Bruce D Hammock; In-Koo Hwang; Qingxiao Li; Naima Moustaid-Moussa; Yeonhwa Park; Stephen Safe; Nanjoo Suh; Sun-Shin Yi; Darryl C Zeldin; Qixin Zhong; Jennifer Alyce Bradbury; Matthew L Edin; Joan P Graves; Hyo-Young Jung; Young-Hyun Jung; Mi-Bo Kim; Woosuk Kim; Jaehak Lee; Hong Li; Jong-Seok Moon; Ik-Dong Yoo; Yiren Yue; Ji-Young Lee; Ho-Jae Han
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.